Overview

Avalere Global Policy 360^® meets a growing need for timely and synthesized information on policy developments in the global life sciences industry.

Attributes

Email updates provide in-depth analysis from Avalere experts on developments in major markets related to coverage and reimbursement policy, health technology assessment, value-based purchasing, strategies for protecting innovation, and global vaccine policy issues. Each news story is accompanied by Avalere’s analysis of the story’s significance and potential impact on US and global policy.

Focus markets include Australia, Canada, China, France, Germany, Italy, Japan, Spain, and the United Kingdom.

Advantages

Stay informed about dynamics abroad and their potential impact in order to support business planning, anticipate impact on US policy, and identify early engagement opportunities.

Membership Benefits

Subscription to easy-to-navigate email updates with a summary description and "Avalere’s Take" on major global policy developments, along with members-only access to a digital archive.

Learn More

Sarah Moselle

Principal

Drawing on Avalere’s expertise in pharmaceutical and vaccine coverage, reimbursement, value, innovation, and preventive health, Sarah Moselle and a team of experts deliver timely and actionable insights and educational resources to keep clients informed on major global developments. These insights can help manufacturer clients identify policy risks and opportunities that transcend borders.

Connect with us to learn more about how Global Policy 360^® can help you keep up to date with major global life sciences policy topics.